Safety-conscious U.S. regulators have taken part of the blame for the drug industry’s monumental problems, many of which center on an inability to bring enough new products to market. But the FDA can point to 2011 as a year that saw a spike in drug app…



January 6th, 2012
Ryan McBride
Posted in
Tags:
